Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingo Kausch

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Pathology, Research and Practice|January 8, 2004
Primitive neuroectodermal tumor (PNET) of the urinary bladderStefan Krüger, Hannelore Schmidt, Ingo Kausch, et al.
Oncology Reports|January 18, 2011
mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinomaFiona Schedel, Ralph Pries, Beate Thode, et al.
European Urology|December 17, 2009
Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studiesIngo Kausch, Martin Sommerauer, Francesco Montorsi, et al.
Urologic Oncology|April 21, 2009
A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancerMerle Hanke, Kai Hoefig, Hartmut Merz, et al.
In Vivo (Athens, Greece)|April 17, 2009
In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancerCaroline E Blietz, Beate Thode, Martin Hauses, et al.
International Journal of Cancer|May 13, 2003
Antisense treatment against Ki-67 mRNA inhibits proliferation and tumor growth in vitro and in vivoIngo Kausch, Anja Lingnau, Elmar Endl, et al.
International Journal of Oncology|April 22, 2008
Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivoDoreen Kunze, Daniela Wuttig, Ingo Kausch, et al.
European Urology Open Science|July 1, 2026
Knowledge Gaps and Barriers to Care in Men with Postprostatectomy Incontinence: Evidence from the German ProKontinenz TrialViktoria Menzel, Christoph Kowalski, Sophie Klara Schellack, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Pathology, Research and Practice|January 8, 2004
Primitive neuroectodermal tumor (PNET) of the urinary bladderStefan Krüger, Hannelore Schmidt, Ingo Kausch, et al.
Oncology Reports|January 18, 2011
mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinomaFiona Schedel, Ralph Pries, Beate Thode, et al.
European Urology|December 17, 2009
Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studiesIngo Kausch, Martin Sommerauer, Francesco Montorsi, et al.
Urologic Oncology|April 21, 2009
A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancerMerle Hanke, Kai Hoefig, Hartmut Merz, et al.
In Vivo (Athens, Greece)|April 17, 2009
In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancerCaroline E Blietz, Beate Thode, Martin Hauses, et al.
International Journal of Cancer|May 13, 2003
Antisense treatment against Ki-67 mRNA inhibits proliferation and tumor growth in vitro and in vivoIngo Kausch, Anja Lingnau, Elmar Endl, et al.
International Journal of Oncology|April 22, 2008
Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivoDoreen Kunze, Daniela Wuttig, Ingo Kausch, et al.
European Urology Open Science|July 1, 2026
Knowledge Gaps and Barriers to Care in Men with Postprostatectomy Incontinence: Evidence from the German ProKontinenz TrialViktoria Menzel, Christoph Kowalski, Sophie Klara Schellack, et al.
Pageof 3